Format

Send to

Choose Destination
N Engl J Med. 2012 Jun 28;366(26):2438-41. doi: 10.1056/NEJMp1205737. Epub 2012 May 30.

Pathological complete response and accelerated drug approval in early breast cancer.

Author information

1
Office of Hematology Oncology Products, Food and Drug Administration, Silver Spring, MD, USA.
PMID:
22646508
DOI:
10.1056/NEJMp1205737
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center